These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 20193740

  • 1. CSF hypocretin-1 concentrations correlate with the level of fatigue in multiple sclerosis patients.
    Papuć E, Stelmasiak Z, Grieb P, Paweł G, Rejdak K.
    Neurosci Lett; 2010 Apr 19; 474(1):9-12. PubMed ID: 20193740
    [Abstract] [Full Text] [Related]

  • 2. Normal levels of cerebrospinal fluid hypocretin-1 and daytime sleepiness during attacks of relapsing-remitting multiple sclerosis and monosymptomatic optic neuritis.
    Knudsen S, Jennum PJ, Korsholm K, Sheikh SP, Gammeltoft S, Frederiksen JL.
    Mult Scler; 2008 Jul 19; 14(6):734-8. PubMed ID: 18505777
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls.
    Goldman MD, Marrie RA, Cohen JA.
    Mult Scler; 2008 Apr 19; 14(3):383-90. PubMed ID: 17942508
    [Abstract] [Full Text] [Related]

  • 4. [Sleepiness and fatigue in multiple sclerosis - comparison of different measuring instruments].
    Kotterba S, Eren E, Fangerau T, Malin JP, Sindern E.
    Fortschr Neurol Psychiatr; 2003 Nov 19; 71(11):590-4. PubMed ID: 14608510
    [Abstract] [Full Text] [Related]

  • 5. The relationship of sleep disturbances and fatigue in multiple sclerosis.
    Attarian HP, Brown KM, Duntley SP, Carter JD, Cross AH.
    Arch Neurol; 2004 Apr 19; 61(4):525-8. PubMed ID: 15096400
    [Abstract] [Full Text] [Related]

  • 6. Normal cerebrospinal fluid levels of hypocretin-1 (orexin A) in patients with fibromyalgia syndrome.
    Taiwo OB, Russell IJ, Mignot E, Lin L, Michalek JE, Haynes W, Xiao Y, Zeitzer JM, Larson AA.
    Sleep Med; 2007 Apr 19; 8(3):260-5. PubMed ID: 17369087
    [Abstract] [Full Text] [Related]

  • 7. Evaluating functional decline in patients with Multiple Sclerosis.
    Rosenblum S, Tamar Weiss PL.
    Res Dev Disabil; 2010 Apr 19; 31(2):577-86. PubMed ID: 20047816
    [Abstract] [Full Text] [Related]

  • 8. Decreased cerebrospinal fluid hypocretin-1 (orexin A) in patients after repetitive generalized tonic-clonic seizures.
    Rejdak K, Papuć E, Grieb P, Stelmasiak Z.
    Epilepsia; 2009 Jun 19; 50(6):1641-4. PubMed ID: 19175390
    [Abstract] [Full Text] [Related]

  • 9. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
    Nishino S, Kanbayashi T.
    Sleep Med Rev; 2005 Aug 19; 9(4):269-310. PubMed ID: 16006155
    [Abstract] [Full Text] [Related]

  • 10. Sleep-wake disturbances 6 months after traumatic brain injury: a prospective study.
    Baumann CR, Werth E, Stocker R, Ludwig S, Bassetti CL.
    Brain; 2007 Jul 19; 130(Pt 7):1873-83. PubMed ID: 17584779
    [Abstract] [Full Text] [Related]

  • 11. Excessive daytime sleepiness in Parkinson's disease: characteristics and determinants.
    Poryazova R, Benninger D, Waldvogel D, Bassetti CL.
    Eur Neurol; 2010 Jul 19; 63(3):129-35. PubMed ID: 20090346
    [Abstract] [Full Text] [Related]

  • 12. Fatigue, mood and quality of life improve in MS patients after progressive resistance training.
    Dalgas U, Stenager E, Jakobsen J, Petersen T, Hansen HJ, Knudsen C, Overgaard K, Ingemann-Hansen T.
    Mult Scler; 2010 Apr 19; 16(4):480-90. PubMed ID: 20194584
    [Abstract] [Full Text] [Related]

  • 13. Fatigued patients with multiple sclerosis have impaired central muscle activation.
    Andreasen AK, Jakobsen J, Petersen T, Andersen H.
    Mult Scler; 2009 Jul 19; 15(7):818-27. PubMed ID: 19465444
    [Abstract] [Full Text] [Related]

  • 14. Cerebrospinal fluid hypocretin-1 levels in multiple system atrophy.
    Martinez-Rodriguez JE, Seppi K, Cardozo A, Iranzo A, Stampfer-Kountchev M, Wenning G, Tolosa E, Högl B, Santamaria J, Poewe W, SINBAR (Sleep Innsbruck Barcelona) group.
    Mov Disord; 2007 Sep 15; 22(12):1822-4. PubMed ID: 17659646
    [Abstract] [Full Text] [Related]

  • 15. Motor assessment of upper extremity function and its relation with fatigue, cognitive function and quality of life in multiple sclerosis patients.
    Yozbatiran N, Baskurt F, Baskurt Z, Ozakbas S, Idiman E.
    J Neurol Sci; 2006 Jul 15; 246(1-2):117-22. PubMed ID: 16678208
    [Abstract] [Full Text] [Related]

  • 16. CSF hypocretin-1 levels are normal in patients with amyotrophic lateral sclerosis.
    Van Rooij FG, Schelhaas HJ, Lammers GJ, Verbeek MM, Overeem S.
    Amyotroph Lateral Scler; 2009 Jul 15; 10(5-6):487-9. PubMed ID: 19922146
    [Abstract] [Full Text] [Related]

  • 17. Neurological disability, psychological distress, and health-related quality of life in MS patients within the first three years after diagnosis.
    Kern S, Schrempf W, Schneider H, Schultheiss T, Reichmann H, Ziemssen T.
    Mult Scler; 2009 Jun 15; 15(6):752-8. PubMed ID: 19482864
    [Abstract] [Full Text] [Related]

  • 18. Fatigue in multiple sclerosis is associated with abnormal cortical activation to voluntary movement--EEG evidence.
    Leocani L, Colombo B, Magnani G, Martinelli-Boneschi F, Cursi M, Rossi P, Martinelli V, Comi G.
    Neuroimage; 2001 Jun 15; 13(6 Pt 1):1186-92. PubMed ID: 11352624
    [Abstract] [Full Text] [Related]

  • 19. CSF orexin-A/hypocretin-1 concentrations in patients with intracerebral hemorrhage (ICH).
    Dohi K, Ripley B, Fujiki N, Ohtaki H, Yamamoto T, Goto Y, Nakamachi T, Shioda S, Aruga T, Nishino S.
    Regul Pept; 2008 Jan 10; 145(1-3):60-4. PubMed ID: 17868933
    [Abstract] [Full Text] [Related]

  • 20. Hypothalamic involvement assessed by T1 relaxation time in patients with relapsing-remitting multiple sclerosis.
    Zellini F, Niepel G, Tench CR, Constantinescu CS.
    Mult Scler; 2009 Dec 10; 15(12):1442-9. PubMed ID: 19995847
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.